Letter to the editor: Survival benefit of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors as conversion therapy for unresectable hepatocellular carcinoma needs more details
肝细胞癌
医学
肿瘤科
免疫检查点
酪氨酸激酶
癌症研究
内科学
免疫疗法
癌症
受体
作者
Dan Wang,Shiming Yi,Xia Liu
出处
期刊:Hepatology [Lippincott Williams & Wilkins] 日期:2025-05-08